The Valley Desk

NCT07587658 · Interventional trial

This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization

Overall registry status Recruiting

Phase 4

Conditions Chronic Obstructive Pulmonary Disease (COPD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov